Percutaneous ozone nucleolysis for lumbar disc herniation

Mohamed Ezeldin, Marco Leonardi, Ciro Princiotta, Massimo Dall’olio, Mohammed Tharwat, Mohammed Zaki, Mohamed E. Abdel-Wanis, Luigi Cirillo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: All percutaneous minimally invasive disc treatments are typically indicated to contained disc herniations. Our study’s aim is to evaluate prospectively the efficacy of ozone nucleolysis in the treatment of either contained or uncontained lumbar disc herniations. Methods: Fifty-two patients, aged 27–87 years, with symptomatic herniated lumbar discs, without migration, sequestration, or severe degenerative disc changes, who failed conservative treatment, were included in our study. The patients underwent fluoroscopic-guided intradiscal oxygen-ozone mixture injection (5 ml) at a concentration of 27–30 μg/ml and periradicular injection of the same O2-O3 mixture (10 ml), steroid (1 ml), and local anesthetic (1 ml). Clinical outcomes were evaluated, based on the Oswestry Disability Index (ODI) and pain intensity (0–5) scale results, obtained initially and at 2- and 6-month controls. Our results were analyzed by ANOVA and chi-squared (χ2) tests. Results: Our initial results obtained at 2-month control were promising, indicating a significant decrease in pain disability and intensity in 74% (37) and 76% (38) of the patients respectively, and minimally increased to 76% (38) and 78% (39) at 6-month control (P < 0.001 and CI 99.9%). The mean preprocedure ODI and pain intensity scores were 35 ± 14.36 and 2.38 ± 0.90, respectively, which were reduced to 19.36 ± 13.12 and 1.04 ± 0.92 at 6-month control. Our failure had been mostly related to long symptoms duration of more than 1 year. No complications were recorded. Conclusion: Ozone nucleolysis is a safe cost-effective minimally invasive technique for treatment of contained and uncontained lumbar disc herniations.

Original languageEnglish
Pages (from-to)1231-1241
Number of pages11
JournalNeuroradiology
Volume60
Issue number11
DOIs
Publication statusPublished - Nov 1 2018

Fingerprint

Ozone
Pain
Steroids
Intervertebral Disc Displacement
Injections
Local Anesthetics
Analysis of Variance
Therapeutics
Oxygen
Costs and Cost Analysis

Keywords

  • Lumbar disc herniation
  • Oswestry Disability Index
  • Ozone
  • Pain

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine

Cite this

Percutaneous ozone nucleolysis for lumbar disc herniation. / Ezeldin, Mohamed; Leonardi, Marco; Princiotta, Ciro; Dall’olio, Massimo; Tharwat, Mohammed; Zaki, Mohammed; Abdel-Wanis, Mohamed E.; Cirillo, Luigi.

In: Neuroradiology, Vol. 60, No. 11, 01.11.2018, p. 1231-1241.

Research output: Contribution to journalArticle

Ezeldin, M, Leonardi, M, Princiotta, C, Dall’olio, M, Tharwat, M, Zaki, M, Abdel-Wanis, ME & Cirillo, L 2018, 'Percutaneous ozone nucleolysis for lumbar disc herniation', Neuroradiology, vol. 60, no. 11, pp. 1231-1241. https://doi.org/10.1007/s00234-018-2083-4
Ezeldin, Mohamed ; Leonardi, Marco ; Princiotta, Ciro ; Dall’olio, Massimo ; Tharwat, Mohammed ; Zaki, Mohammed ; Abdel-Wanis, Mohamed E. ; Cirillo, Luigi. / Percutaneous ozone nucleolysis for lumbar disc herniation. In: Neuroradiology. 2018 ; Vol. 60, No. 11. pp. 1231-1241.
@article{50a4a37fea544603b82e261b2159701a,
title = "Percutaneous ozone nucleolysis for lumbar disc herniation",
abstract = "Purpose: All percutaneous minimally invasive disc treatments are typically indicated to contained disc herniations. Our study’s aim is to evaluate prospectively the efficacy of ozone nucleolysis in the treatment of either contained or uncontained lumbar disc herniations. Methods: Fifty-two patients, aged 27–87 years, with symptomatic herniated lumbar discs, without migration, sequestration, or severe degenerative disc changes, who failed conservative treatment, were included in our study. The patients underwent fluoroscopic-guided intradiscal oxygen-ozone mixture injection (5 ml) at a concentration of 27–30 μg/ml and periradicular injection of the same O2-O3 mixture (10 ml), steroid (1 ml), and local anesthetic (1 ml). Clinical outcomes were evaluated, based on the Oswestry Disability Index (ODI) and pain intensity (0–5) scale results, obtained initially and at 2- and 6-month controls. Our results were analyzed by ANOVA and chi-squared (χ2) tests. Results: Our initial results obtained at 2-month control were promising, indicating a significant decrease in pain disability and intensity in 74{\%} (37) and 76{\%} (38) of the patients respectively, and minimally increased to 76{\%} (38) and 78{\%} (39) at 6-month control (P < 0.001 and CI 99.9{\%}). The mean preprocedure ODI and pain intensity scores were 35 ± 14.36 and 2.38 ± 0.90, respectively, which were reduced to 19.36 ± 13.12 and 1.04 ± 0.92 at 6-month control. Our failure had been mostly related to long symptoms duration of more than 1 year. No complications were recorded. Conclusion: Ozone nucleolysis is a safe cost-effective minimally invasive technique for treatment of contained and uncontained lumbar disc herniations.",
keywords = "Lumbar disc herniation, Oswestry Disability Index, Ozone, Pain",
author = "Mohamed Ezeldin and Marco Leonardi and Ciro Princiotta and Massimo Dall’olio and Mohammed Tharwat and Mohammed Zaki and Abdel-Wanis, {Mohamed E.} and Luigi Cirillo",
note = "Ricercatore distaccato presso IRCCS a seguito Convenzione esclusiva con Universit{\`a} di Bologna (Luigi Cirillo). Pubblicata {"}CORRECTION{"} per modifica di affiliazione (inserito nel pdf della pubblicazione qui allegato).",
year = "2018",
month = "11",
day = "1",
doi = "10.1007/s00234-018-2083-4",
language = "English",
volume = "60",
pages = "1231--1241",
journal = "Neuroradiology",
issn = "0028-3940",
publisher = "Springer Verlag",
number = "11",

}

TY - JOUR

T1 - Percutaneous ozone nucleolysis for lumbar disc herniation

AU - Ezeldin, Mohamed

AU - Leonardi, Marco

AU - Princiotta, Ciro

AU - Dall’olio, Massimo

AU - Tharwat, Mohammed

AU - Zaki, Mohammed

AU - Abdel-Wanis, Mohamed E.

AU - Cirillo, Luigi

N1 - Ricercatore distaccato presso IRCCS a seguito Convenzione esclusiva con Università di Bologna (Luigi Cirillo). Pubblicata "CORRECTION" per modifica di affiliazione (inserito nel pdf della pubblicazione qui allegato).

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Purpose: All percutaneous minimally invasive disc treatments are typically indicated to contained disc herniations. Our study’s aim is to evaluate prospectively the efficacy of ozone nucleolysis in the treatment of either contained or uncontained lumbar disc herniations. Methods: Fifty-two patients, aged 27–87 years, with symptomatic herniated lumbar discs, without migration, sequestration, or severe degenerative disc changes, who failed conservative treatment, were included in our study. The patients underwent fluoroscopic-guided intradiscal oxygen-ozone mixture injection (5 ml) at a concentration of 27–30 μg/ml and periradicular injection of the same O2-O3 mixture (10 ml), steroid (1 ml), and local anesthetic (1 ml). Clinical outcomes were evaluated, based on the Oswestry Disability Index (ODI) and pain intensity (0–5) scale results, obtained initially and at 2- and 6-month controls. Our results were analyzed by ANOVA and chi-squared (χ2) tests. Results: Our initial results obtained at 2-month control were promising, indicating a significant decrease in pain disability and intensity in 74% (37) and 76% (38) of the patients respectively, and minimally increased to 76% (38) and 78% (39) at 6-month control (P < 0.001 and CI 99.9%). The mean preprocedure ODI and pain intensity scores were 35 ± 14.36 and 2.38 ± 0.90, respectively, which were reduced to 19.36 ± 13.12 and 1.04 ± 0.92 at 6-month control. Our failure had been mostly related to long symptoms duration of more than 1 year. No complications were recorded. Conclusion: Ozone nucleolysis is a safe cost-effective minimally invasive technique for treatment of contained and uncontained lumbar disc herniations.

AB - Purpose: All percutaneous minimally invasive disc treatments are typically indicated to contained disc herniations. Our study’s aim is to evaluate prospectively the efficacy of ozone nucleolysis in the treatment of either contained or uncontained lumbar disc herniations. Methods: Fifty-two patients, aged 27–87 years, with symptomatic herniated lumbar discs, without migration, sequestration, or severe degenerative disc changes, who failed conservative treatment, were included in our study. The patients underwent fluoroscopic-guided intradiscal oxygen-ozone mixture injection (5 ml) at a concentration of 27–30 μg/ml and periradicular injection of the same O2-O3 mixture (10 ml), steroid (1 ml), and local anesthetic (1 ml). Clinical outcomes were evaluated, based on the Oswestry Disability Index (ODI) and pain intensity (0–5) scale results, obtained initially and at 2- and 6-month controls. Our results were analyzed by ANOVA and chi-squared (χ2) tests. Results: Our initial results obtained at 2-month control were promising, indicating a significant decrease in pain disability and intensity in 74% (37) and 76% (38) of the patients respectively, and minimally increased to 76% (38) and 78% (39) at 6-month control (P < 0.001 and CI 99.9%). The mean preprocedure ODI and pain intensity scores were 35 ± 14.36 and 2.38 ± 0.90, respectively, which were reduced to 19.36 ± 13.12 and 1.04 ± 0.92 at 6-month control. Our failure had been mostly related to long symptoms duration of more than 1 year. No complications were recorded. Conclusion: Ozone nucleolysis is a safe cost-effective minimally invasive technique for treatment of contained and uncontained lumbar disc herniations.

KW - Lumbar disc herniation

KW - Oswestry Disability Index

KW - Ozone

KW - Pain

UR - http://www.scopus.com/inward/record.url?scp=85053506574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053506574&partnerID=8YFLogxK

U2 - 10.1007/s00234-018-2083-4

DO - 10.1007/s00234-018-2083-4

M3 - Article

C2 - 30206674

AN - SCOPUS:85053506574

VL - 60

SP - 1231

EP - 1241

JO - Neuroradiology

JF - Neuroradiology

SN - 0028-3940

IS - 11

ER -